You are here: Industry Insights > DCGI

News List

Dr Reddy’s gets DCGI nod for Phase 3 clinical trial for Sputnik V vaccine expresspharma
January 18, 2021
The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Bharat Biotech to make 700 million doses in 2021 expresspharma
January 06, 2021
Dr Krishna Ella, Chairman and MD Bharat Biotech said that Covaxin trials '200 per cent honest'.
Drug activist group AIDAN raises concerns over EUA for COVAXIN expresspharma
January 05, 2021
The All India Drug Action Network (AIDAN), a drug activists group has issued a statement asking the DCGI to make public all the data and analyses on which the decisions have been made to grant EUA to the COVID-19 vaccines.
Mixed reactions from healthcare experts, activists over REU for Covaxin, Covishield expresspharma
January 05, 2021
Some ask for more transparency in the approval process and seek data related to vaccine trials while others say that grant of REU in clinical trial mode in an emergency situation is in public interest.
DCGI approves Covishield and Covaxin for restricted emergency use in India expresspharma
January 04, 2021
DCGI’s decision comes after the Subject Expert Committee of CDSCO met on January 1-2, 2021 and recommended the grant of permission for restricted emergency use of these vaccines.
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D expresspharma
January 04, 2021
The company will now be initiating Phase III clinical trial in around 30,000 volunteer.
AstraZeneca’s Asthma drug Benralizumab gets marketing approval from DCGI expresspharma
December 23, 2020
Fasenra is an add-on maintenance treatment for patients with severe eosinophilic asthma.
AstraZeneca Pharma India gets DCGI nod for benralizumab injection, Fasenra expresspharma
December 22, 2020
It is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients.
Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials expresspharma
December 14, 2020
It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Science & Technology.
Many Indians are sceptical of taking COVID-19 vaccine: LocalCircles survey expresspharma
December 09, 2020
LocalCircles recently conducted a survey to gauge acceptance for COVID-19 vaccines in the country which reportedly received 25,000+ responses from citizens across 262 districts of India.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page